MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Aging"

  • 2018 International Congress

    Screening performance of abbreviated versions of the UPSIT smell test

    T. Joseph, S. Auger, L. Peress, D. Rack, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To compare the screening performance of existing abbreviated (4-12 item) versions of the 40-item University of Pennsylvania Smell Identification Test (UPSIT), and to identify…
  • 2018 International Congress

    Role of metformin in diabetic aging female rat brain: a future therapy for neurodegenerative diseases

    P. Kumar, N. Baquer (New Delhi, India)

    Objective: The objective of this study was to investigate effects of metformin on glucose transporter (GLUT1, GLUT3) expression, intracellular calcium levels, expression of synaptic molecules…
  • 2018 International Congress

    Lottery choice task as a detect tool for PD patients with pathological gambling

    W. Liu, R. Wu, J. Goh (Hualien, Taiwan)

    Objective: We aim to develop a tool lack of stigma to detect patients' impulse control problems. Background: Dopaminergic medication is current major treatment for Parkinson's…
  • 2018 International Congress

    Primary familial brain calcification – The impact of calcifications on the development of motor symptoms

    D. Alvarez-Fischer, C. Schiemenz, G. Mahlke, A. Keller, A. Westenberger, J. Erdmann, Z. Aherrahrou, C. Klein (Lübeck, Germany)

    Objective: The aim of the present study was to investigate whether the nigro-striatal system in a genetic mouse model of primary familial brain calcification (PFBC)…
  • 2018 International Congress

    Degeneration of vagus nerve but not of accessory and phrenic nerve in Parkinson’s disease revealed by high-resolution ultrasound

    U. Walter, P. Tsiberidou, M. Kersten, A. Storch, M. Löhle (Rostock, Germany)

    Objective: To test the hypothesis that the vagus nerve is measurably atrophic in idiopathic Parkinson’s disease (PD). Background: The vagus nerve is discussed to represent…
  • 2018 International Congress

    Outcomes of elective orthopedic surgery in Parkinson’s disease – a Nationwide study

    M. Fullard, D. Thibault, A. Willis (Philadelphia, PA, USA)

    Objective: Provide national outcomes on readmissions after elective orthopedic surgery in Parkinson’s disease (PD). Background: Advances in the treatment of PD have allowed for improvements…
  • 2018 International Congress

    Effects of Glial Heme Oxygenase-1 on Neuronal Alpha-Synuclein in the GFAP.HMOX1 Mouse Model of Parkinson’s Disease

    M. Cressatti, W. Song, A. Turk, C. Galindez, H. Schipper (Montreal, QC, Canada)

    Objective: To determine whether astroglial HO-1 transduces environmental and endogenous stressors into patterns of neural damage which promote the toxicity of neuronal alpha-synuclein. Background: The…
  • 2018 International Congress

    Antihypertensive medications have protective associations with PD outcomes in PD-hypertension

    V. Kotagal (Ann Arbor, MI, USA)

    Objective: We explored the associations between markers of clinical decline and antihypertensive use in subjects with both Parkinson disease (PD) and hypertension (HTN) Background: Comorbid…
  • 2018 International Congress

    Life Expectancy for Parkinson Patients at Hoehn and Yahr Stage 5

    W. Li, H.L. Ng, S. Acharyya, K.Y. Tay, W.L. Au, L. Tan (Singapore, Singapore)

    Objective: this study was carried out to analyze the average time taken for parkinson patients to progress from HY stage 5 to death, and investigate…
  • 2018 International Congress

    Preliminary evaluation of the Integrated Parkinson’s Care Network (IPCN): An integrated care model for complex needs

    T. Mestre, D. Kessler, D. Coté, K. Thavorn, C. Liddy, M. Taljaard, D. Grimes (Ottawa, ON, Canada)

    Objective: To conduct a preliminary evaluation of the IPCN for: 1) proof of concept, 2) processes refinement for its evaluation, and 3) assess the feasibility…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 26
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley